Mobocertinib (TAK788)

Mobocertinib (TAK788, AP32788), an investigational TKI, is a potent, selective preclinical inhibitor of epidermal growth factor receptor (EGFR) and HER2 mutations. Mobocertinib (TAK788) is an antineoplastic agent.

Price Not Available 25mg Mobocertinib (TAK788) Supplier Page

Trivial name	AP32788
Catalog Number	S6813
Molecular Formula	C32H39N7O4
CAS#	1847461-43-1
Inchi	InChI=1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35, 36)
Inchi Key	AZSRSNUQCUDCGG-UHFFFAOYSA-N
SMILES	CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
Size	25mg
Supplier Page	http://www.selleckchem.com/products/tak788.html
Additional Information	https://file.selleck.cn/downloads/struct/tak788-chemical-structure-s6813.gif